Skip to content
Home
Our Science
Pipeline & Assets
Team & Investors
Careers
News & Resources
Connect
News
& Resources
Featured Stories
GlobeNewswire
Siren Biotechnology Awarded $8M in Non-Dilutive Grant Funding from CIRM to Support Clinical Development of SRN-101 in High-Grade Glioma
Read More
Siren Biotechnology Announces FDA Clearance of First IND, Advancing Company to Clinical Stage
Read More
GlobeNewswire
Siren Biotechnology Publishes Foundational AAV Immuno-Gene Therapy Data and Announces Presentations at ASGCT 2026
Read More
News
Patient Resources
Videos
Publications & Presentations
BioTech TV @ ASGCT 2026: Siren Biotechnology recently has seen two INDs cleared for its AAV based gene therapy for oncology.
1
2
3
4
